Sotera Health

SHC | NASDAQ

Price Alert Chart Builder DCF Calculator

$18.14

-$0.56 (-2.99%)

At close: Oct 30, 2026, 3:59 PM ET

$18.15

+$0.01 (+0.06%)

After-hours: Oct 30, 2026, 4:33 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-2.99%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Nov 2, 2026

65.2

+5.5 pts

Fundamentals Strong

Market Sentiment Neutral

Moat Narrow

Sector Rank #94/1028 (Top 9%)

Full Analysis

Key Statistics

Market Data

Market Cap $5.17B

1D Range

17.88 18.87

52W Range

13.13 19.57

Valuation (TTM)

PE 31.82

PB 7.77

EV/EBITDA 13.13

Valuation (NTM)

Forward PE 17.32

Forward PEG 1.83

Price Target $21.33

Cash Flow

FCF Yield 2.2%

SBC Adj. FCF Yield 1.5%

SBC Impact -32.9%

Margins

Gross Margin 54.7%

Operating Margin 36.2%

FCF Margin 9.3%

Growth (CAGR)

Revenue 3Y | 5Y 7.6% | 6.7%

Dil EPS 3Y | 5Y 81.2% | 95.4%

FCF 3Y | 5Y 47.1% | -2.4%

Returns

ROA 4.9%

ROE 26.8%

ROIC 8.8%

Financial Health

Net Debt

$1.79B

Current Ratio 2.80

Interest Coverage 3.07

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Sotera Health Company, headquartered in Broadview Heights, Ohio, delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and v...

Sector Healthcare

Industry Medical - Diagnostics & Research

Employees 3,000

IPO Date Nov 20, 2020

Website soterahealth.com

Fiscal Year January - December

Full Company Profile

Latest News

12 days ago · globenewswire.com

Sotera Health Announces Third-Quarter 2026 Earnings Release Date

CLEVELAND, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the third quarter ended September 30, 2026 before the market opens on Tuesday, November 3, 2026. Following the release, management will host a conference call at 9:00 a.m.

1 month ago · seekingalpha.com

Sotera Health: Pricing Power And Recurring Revenues Are Growth Drivers

Sotera Health Company is rated BUY, leveraging a vertically integrated model and strong MOAT in global medical equipment sterilization. SHC benefits from high customer switching costs, multi-year contracts with major healthcare firms, and robust pricing power in mission critical services. Q2 2026 results exceeded expectations, prompting raised full-year guidance; SHC trades at a discount to peers on forward EV/EBITDA despite superior margins.

2 months ago · seekingalpha.com

Sotera Health Company (SHC) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

3 months ago · marketbeat.com

Sotera Health Q2 Earnings Call Highlights

Sotera Health NASDAQ: SHC reported second-quarter 2026 results that included 8% constant-currency revenue growth, higher adjusted EBITDA margins and an increase to its full-year revenue and adjusted EBITDA outlook.

3 months ago · seekingalpha.com

Sotera Health Company (SHC) Q2 2026 Earnings Call Transcript

3 months ago · zacks.com

Sotera Health (SHC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Sotera Health (SHC) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

3 months ago · globenewswire.com

Sotera Health Announces Second-Quarter 2026 Earnings Release Date

CLEVELAND, July 23, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the second-quarter ended June 30, 2026 before the market opens on Thursday, August 6, 2026. Following the release, management will host a conference call at 9:00 a.m.